DAB.bio is a startup based in the Netherlands, most recent round Series B, 3 tracked investors.
Based in the Netherlands, DAB.bio is a startup. Its most recent tracked round is Series B. Brouky records 3 investors associated with the company.
DAB.bio is a biotechnology company that develops and deploys cutting-edge fermentation technology, specifically the patented FAST platform, which enables continuous fermentation and significantly reduces manufacturing costs for bio-based chemicals, fuels, and proteins.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.